Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
 
Sign in
Join now
Chill Yee MD
Chill C. Yee MD Advisory Board
Irene Hamrick MD, FAAFP, AGSF, CMD
Irene Hamrick MD, FAAFP, AGSF, CMD Advisory Board
Tricia Elliott MD, FAAFP
Tricia C. Elliott MD, FAAFP Associate Editor
See All Experts
story of the week
Published in Primary Care and
2 other channels

Journal Scan / Research · September 01, 2022

Association of Nirmatrelvir Use With Severe COVID-19 Outcomes During the Omicron Predominance

The New England Journal of Medicine

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Peter Lin MD, CCFP

The New England Journal of Medicine
Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge
N. Engl. J. Med 2022 Aug 24;[EPub Ahead of Print], R Arbel, Y Wolff Sagy, M Hoshen, E Battat, G Lavie, R Sergienko, M Friger, JG Waxman, N Dagan, R Balicer, Y Ben-Shlomo, A Peretz, S Yaron, D Serby, A Hammerman, D Netzer

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated